Business & Economy
Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Source: Business News · Published
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Related stories
Chipotle shares rise 7% after CEO says same-store sales growth will continue
For the first time this year, low-income consumers during the quarter outperformed the high-income cohort at its restaurants, CEO Scott Boatwright said.
Business News ·
Poundland's future hangs in the balance as chain edges towards collapse
Poundland's bosses is filing a notice of intention to appoint administrators to the business.
feeds.bbci.co.uk ·
Bereaved families will not face tax bill over pension delays under new rules
Campaigners had warned some families could face an unfair financial penalty because of delays which were not their fault.
feeds.bbci.co.uk ·
Your pay, energy bills and savings: How the Budget affects you
Changes announced by Chancellor John Healey in his first Budget will affect your finances directly. Here's how.
feeds.bbci.co.uk ·
Doordash to buy Instacart in $17bn deal it says will expand customer options
Instacart shoppers will be able to buy from 150,000 stores, compared to the 100,000 currently available on the platform, the firms said.
feeds.bbci.co.uk ·